Phibro Animal Health (PAHC) Retained Earnings (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Retained Earnings came in at -$112.5 million in Q1 2026, down 143.2% year-on-year from $260.3 million in Q1 2025, and down 135.48% quarter-over-quarter from $317.0 million in Q4 2025.
Phibro Animal Health (PAHC) Retained Earnings (2013 - 2026) Analysis & Trends
Phibro Animal Health's Retained Earnings history runs 14 years deep, the most recent figure standing at -$112.5 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 143.2% year-over-year to -$112.5 million in Q1 2026; TTM through Mar 2026 was -$112.5 million, a 143.2% decrease from a year earlier, with the FY2025 full-year figure at -$124.0 million, changed 0.4% from the prior year.
- Retained Earnings slipped to -$112.5 million in Q1 2026 per PAHC's latest filing, from $317.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $317.0 million in Q4 2025 and bottomed at -$124.0 million in Q2 2025.
- The 5-year median for Retained Earnings is $244.3 million (2024), against an average of $82.9 million.
- Across the five-year window, Retained Earnings plunged 149.97% in 2024 and jumped 337.51% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$116.5 million in 2022, then increased by 5.93% to -$109.6 million in 2023, then jumped by 322.89% to $244.3 million in 2024, then rose by 29.73% to $317.0 million in 2025, then plunged by 135.48% to -$112.5 million in 2026.
- Per Business Quant, the three latest PAHC Retained Earnings figures stand at -$112.5 million (Q1 2026), $317.0 million (Q4 2025), and $294.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | -112.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.47 Mn |
| Dec 31, 2025 | 316.96 Mn |
| Sep 30, 2025 | 294.36 Mn |
| Jun 30, 2025 | -124.02 Mn |
| Mar 31, 2025 | 260.34 Mn |
| Dec 31, 2024 | 244.33 Mn |
| Sep 30, 2024 | -123.94 Mn |
| Jun 30, 2024 | -123.53 Mn |
| Mar 31, 2024 | 248.00 Mn |
| Dec 31, 2023 | -109.62 Mn |
| Sep 30, 2023 | 248.04 Mn |
| Jun 30, 2023 | -114.21 Mn |
| Mar 31, 2023 | -117.75 Mn |
| Dec 31, 2022 | -116.53 Mn |
| Sep 30, 2022 | 246.74 Mn |
| Jun 30, 2022 | 247.75 Mn |
| Mar 31, 2022 | 245.12 Mn |
| Dec 31, 2021 | -128.81 Mn |
| Sep 30, 2021 | 219.69 Mn |
| Jun 30, 2021 | -115.29 Mn |